Abliva AB (publ) (NEVPF)

USD 0.04

(0.0%)

Long Term Debt Summary of Abliva AB (publ)

  • Abliva AB (publ)'s latest annual long term debt in 2023 was 42.04 Thousand USD , down -17.85% from previous year.
  • Abliva AB (publ)'s latest quarterly long term debt in 2024 Q2 was 216 Thousand USD , down 0.0% from previous quarter.
  • Abliva AB (publ) reported annual long term debt of 51.18 Thousand USD in 2022, down 0.0% from previous year.
  • Abliva AB (publ) reported annual long term debt of - USD in 2021, down -100.0% from previous year.
  • Abliva AB (publ) reported quarterly long term debt of 216 Thousand USD for 2024 Q2, down 0.0% from previous quarter.
  • Abliva AB (publ) reported quarterly long term debt of 57.2 Thousand USD for 2023 Q2, down -16.49% from previous quarter.

Annual Long Term Debt Chart of Abliva AB (publ) (2023 - 2007)

Historical Annual Long Term Debt of Abliva AB (publ) (2023 - 2007)

Year Long Term Debt Long Term Debt Growth
2023 42.04 Thousand USD -17.85%
2022 51.18 Thousand USD 0.0%
2021 - USD -100.0%
2020 92 Thousand USD 138.67%
2019 38.54 Thousand USD 0.0%
2018 - SEK 0.0%
2017 - SEK 0.0%
2016 - SEK 0.0%
2015 - SEK 0.0%
2014 - SEK 0.0%
2013 - SEK 0.0%
2012 - SEK 0.0%
2011 - SEK 0.0%
2010 - SEK 0.0%
2009 - SEK 0.0%
2008 - SEK 0.0%
2007 - SEK 0.0%

Peer Long Term Debt Comparison of Abliva AB (publ)

Name Long Term Debt Long Term Debt Difference
Eiger BioPharmaceuticals, Inc. - USD -Infinity%
Nanobac Pharmaceuticals, Incorporated - USD -Infinity%
SQZ Biotechnologies Company 20.9 Million USD 99.799%
Evofem Biosciences, Inc. 8000.00 USD -425.575%
Santhera Pharmaceuticals Holding AG 1.75 Million USD 97.605%
Mesoblast Limited 100.29 Million USD 99.958%
Propanc Biopharma, Inc. 58.64 Thousand USD 28.301%
Genus plc 228.2 Million USD 99.982%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
CNBX Pharmaceuticals Inc. - USD -Infinity%
Marizyme, Inc. 667.12 Thousand USD 93.697%
ContraFect Corporation 2.21 Million USD 98.097%
Nymox Pharmaceutical Corporation - USD -Infinity%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 1.4 Million USD 97.003%
Intellipharmaceutics International Inc. - USD -Infinity%
AXIM Biotechnologies, Inc. 5.42 Million USD 99.225%
MultiCell Technologies, Inc. 36.43 USD -115315.866%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 55.61 Million USD 99.924%
EV Biologics, Inc. - USD -Infinity%
Q BioMed Inc. - USD -Infinity%
Emmaus Life Sciences, Inc. 2.22 Million USD 98.111%
Neon Bloom, Inc. - USD -Infinity%
Mosaic ImmunoEngineering Inc. 1.22 Million USD 96.577%
Biomind Labs Inc. - USD -Infinity%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Pharming Group N.V. 166.1 Million USD 99.975%
Oncotelic Therapeutics, Inc. 1.89 Million USD 97.785%
Skye Bioscience, Inc. 171.23 Thousand USD 75.445%
Therapeutic Solutions International, Inc. 5512.00 USD -662.808%
THC Farmaceuticals, Inc. - USD -Infinity%
Arch Therapeutics, Inc. - USD -Infinity%
IMV Inc. 27.39 Million USD 99.847%
Acro Biomedical Co., Ltd. - USD -Infinity%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. 322 Thousand USD 86.942%
Alpha Cognition Inc. - USD -Infinity%
HST Global, Inc. - USD -Infinity%
CSL Limited 11.23 Billion USD 100.0%
Halberd Corporation 150 Thousand USD 71.969%
Enzolytics Inc. - USD -Infinity%
Resverlogix Corp. - USD -Infinity%
Affymax, Inc. - USD -Infinity%
SYBLEU INC 300 Thousand USD 85.985%
Nuo Therapeutics, Inc. 164.2 Thousand USD 74.394%
argenx SE 15.35 Million USD 99.726%
MetaStat, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. 20.31 Million USD 99.793%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Arno Therapeutics, Inc. - USD -Infinity%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. - USD -Infinity%
Zenith Capital Corp. 4456.00 USD -843.582%
Genscript Biotech Corporation 287.12 Million USD 99.985%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. 126.3 Thousand USD 66.71%
WPD Pharmaceuticals Inc. 229.29 Thousand USD 81.663%
American Oriental Bioengineering, Inc. 554.59 Thousand USD 92.419%
Provectus Biopharmaceuticals, Inc. 25.29 Thousand USD -66.196%
Adynxx, Inc. - USD -Infinity%
Helix BioMedix, Inc. - USD -Infinity%
GlobeStar Therapeutics Corporation - USD -Infinity%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Capstone Therapeutics Corp. 8.26 Million USD 99.491%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
BioStem Technologies, Inc. 265.63 Thousand USD 84.172%
ONE Bio Corp. 592.19 Thousand USD 92.9%
Reve Technologies, Inc. 1064.00 USD -3851.692%
Burzynski Research Institute, Inc. - USD -Infinity%
Wesana Health Holdings Inc. - USD -Infinity%
Agentix Corp. - USD -Infinity%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
ProtoKinetix, Incorporated - USD -Infinity%
Regen BioPharma, Inc. 149.61 Thousand USD 71.897%
Regen BioPharma, Inc. 149.61 Thousand USD 71.897%
NovAccess Global Inc. - USD -Infinity%
Endonovo Therapeutics, Inc. - USD -Infinity%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
Kadimastem Ltd 229.69 Thousand USD 81.695%
Oncology Pharma Inc. - USD -Infinity%
Institute of Biomedical Research Corp. - USD -Infinity%
CytoDyn Inc. 141 Thousand USD 70.18%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Qrons Inc. 80 Thousand USD 47.443%
Alseres Pharmaceuticals, Inc. 7.81 Million USD 99.462%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
Nascent Biotech, Inc. - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. 369.04 Thousand USD 88.607%
International Stem Cell Corporation 445 Thousand USD 90.551%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 8.15 Million USD 99.484%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. 457 Thousand USD 90.8%
Neutra Corp. - USD -Infinity%
Windtree Therapeutics, Inc. 1.16 Million USD 96.378%
PureTech Health plc 18.25 Million USD 99.77%
Coeptis Therapeutics, Inc. 150 Thousand USD 71.969%
IXICO plc 275 Thousand USD 84.711%
IntelGenx Technologies Corp. 11.83 Million USD 99.645%
Gelesis Holdings, Inc. 26.3 Million USD 99.84%
CSL Limited 11.23 Billion USD 100.0%
Cellectis S.A. 36.21 Million USD 99.884%